Dan Burns

Biography

 Mr. Burns joined InfaCare Pharmaceutical as President and Chief Executive Officer in April 2007, bringing to the company more than 20 years of management experience in the pharmaceutical and biotechnology industries. Prior to joining InfaCare, from 2002 to 2007 Mr. Burns was a Corporate Officer at MannKind Corporation and held the positions of CEO PDC, President Commercial Operations, and President MannKind BioPharmaceuticals. He led the building of the Technosphere Technology Platform enabling the company to successfully complete a public offering in 2004. Mr. Burns served as Chief Executive Officer of HealthTalk Interactive, a pharmaceutical services firm, from 2000 to 2002. From 1998 to 1999 Mr. Burns served as Chief Executive Officer of ProScript, a biopharmaceutical company when the company filed an IND for Velcade and proceeded to the clinic. He subsequently negotiated the sale of ProScript to a public biopharmaceutical company. Mr. Burns served as President and Chief Operating Officer of Trophix Pharmaceuticals Inc. from 1997 to 1998 where he successfully merged Trophix with the largest public biopharmaceutical company in Canada. Prior to joining Trophix Mr. Burns held a number of senior executive positions both internationally and domestically with Bristol Myers Squibb.    

Research Interest

pharmaceutical and biotechnology